Table of contents

Clinical and epidemiological research

• Extended report: Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study (19 November, 2013) Free

  Nicola Dalbeth, Peggy Chen, Marie White, Gregory D Gamble, Caran Barratt-Boyes, Peter J Gow, Brandon Orr-Walker
• Extended report: Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study (28 January, 2014)

  Maxime Dougados, Karsten Kissel, Philip G Conaghan, Emilio Martin Mola, Georg Schett, Roberto Gerli, Michael Sejer Hansen, Howard Amital, Ricardo M Xavier, Orrin Troum, Corrado Bernasconi, T W J Huizinga
• Extended report: The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy (13 February, 2014)

  Philip G Conaghan, Charles Peterfy, Ewa Olech, Jeffrey Kaine, David Ridley, Julie DiCarlo, Josh Friedman, Jenny Devenport, Orrin Troum
• Extended report: Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS) (3 January, 2014)

  Denis Poddubnyy, Kay-Geert A Hermann, Johanna Callhoff, Joachim Listing, Joachim Sieper
• Extended report: Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative (12 April, 2013)

  Laura L Laslett, Sarah R Kingsbury, Elizabeth M A Hensor, Michael A Bowes, Philip G Conaghan
• Extended report: Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24 (20 April, 2013)

  David Saadoun, M Resche Rigon, V Thibault, M Longuet, S Pol, F Blanc, G Pialoux, A Karras, D Bazin-Karra, C Cazorla, D Vittecoq, L Musset, O Decaux, J M Ziza, O Lambotte, Patrice Cacoub
• Extended report: Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials (22 March, 2013)

  Vibeke Strand, Roger A Levy, Ricard Cervera, Michelle A Petri, Helen Birch, William W Freimuth, Z John Zhong, Ann E Clarke, for the BLISS-52 and -76 Study Groups
• Extended report: Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort (21 March, 2013)

  Tor Olofsson, Ingemar F Petersson, Jonas K Eriksson, Martin Englund, Julia F Simard, Jan-Åke Nilsson, Pierre Geborek, Lennart T H Jacobsson, Johan Askling, Martin Neovius
• Extended report: Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies (21 March, 2013)

  Arnd Kleyer, Stephanie Finzel, Jürgen Rech, Bernhard Manger, Manuel Krieter, Francesca Faustini, Elisabeth Araujo, Axel J Hueber, Ulrike Harre, Klaus Engelke, Georg Schett
• Extended report: What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review (9 April, 2013)

  J A B van Nies, A Krabben, J W Schoones, T W J Huizinga, M Kloppenburg, A H M van der Helm-van Mil
• Extended report: Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis (18 April, 2013)

  Eva Salgado, Jose R Maneiro, Loreto Carmona, Juan J Gomez-Reino
• Extended report: The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women (10 April, 2013)

  Carrie A Karvonen-Gutierrez, Siobán D Harlow, Jon Jacobson, Peter Mancuso, Yebin Jiang
• Extended report: Genetics of toll like receptor 9 in ANCA associated vasculitides (16 April, 2013)

  C A Husmann, J U Holle, F Moosig, S Mueller, B Wilde, J W Cohen Tervaert, L Harper, G Assmann, W L Gross, J T Epplen, S Wieczorek
• Extended report: FMF50: a score for assessing outcome in familial Mediterranean fever (25 February, 2014)

  Seza Ozen, Erkan Demirkaya, Ali Duzova, Ozlem Erdogan, Eren Erken, Ahmet Gul, Ozgur Kasapcopur, Timucin Kasifoglu, Bunyamin Kisacik, Huri Ozdogan, Mehmet Tunca, Cengizhan Acikel, for the FMF Arthritis Vasculitis and Orphan disease Research in pediatric rheumatology (FAVOR) and Turkish FMF study group
• Concise report: Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project (6 August, 2013)

  Michaela A Stoffer, Josef S Smolen, Anthony Woolf, Ales Ambrozic, Ailsa Bosworth, Loreto Carmona, Veronika Fialka-Moser, Estibaliz Loza, Pawel Olejnik, Ingemar F Petersson, Till Uhlig, Tanja A Stamm, the eumusc.net-working group
• Concise r eport: Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project (19 August, 2013)

  Ingemar F Petersson, Britta Strömbeck, Lene Andersen, Marco Cimmino, Rolf Greiff, Estibaliz Loza, Carlo Sciré, Tanja Stamm, Michaela Stoffer, Till Uhlig, Anthony D Woolf, Theodora P M Vliet Vlieland, the eumusc.net-working group
• Concise report: Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy (2 January, 2014)

  Sudipto Das, Edward M Vital, Sarah Horton, Domini Bryer, Yasser El-Sherbiny, Andrew C Rawstron, Frederique Ponchel, Paul Emery, Maya H Buch